Vertex Pharmaceuticals, Inc. (VRTX)
447.81
+4.85
(+1.09%)
USD |
NASDAQ |
Jun 09, 14:17
Vertex Pharmaceuticals SG&A Expense (Quarterly) : 493.70M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 647.70M |
| Biogen, Inc. | 607.30M |
| CRISPR Therapeutics AG | 17.18M |
| Halozyme Therapeutics, Inc. | 57.88M |
| Gilead Sciences, Inc. | 1.451B |